Health ministry was warned over promotion of puberty blockers
Melbourne’s Royal Children’s Hospital Gender Services website’s version of the reversibility of puberty blockers:
Puberty blockers suppress the development of secondary sex characteristics and are used for adolescents in the early stages of pubertal development. As they are reversible in their effects, should an adolescent wish to stop taking them at any time, their biological puberty will resume.
Compared with the new-found caution from the NZ Ministry of Health:
The government’s own regulator, Medsafe, raised this risk last September when ministry officials were discussing a more cautious website reference to puberty blockers. The ministry’s website previously had claimed these drugs were “a safe and fully reversible medicine” for children with gender distress. Known as GnRH analogues, these hormone suppression drugs have various approved uses; trans puberty blocking is not one of them.